SOCIETY ENDORSEMENTS
AGENDA
*Agenda is subject to change.
8:00 AM – 9:00 AM CDT
Breakfast
9:00 AM – 9:10 AM CDT
Welcome
Lawrence Schiller, MD
9:10 AM – 9:35 AM CDT
Viral Hepatitis B & C: Diagnosis, Management, and Monitoring
Mark Sulkowski, MD
9:35 AM – 10:00 AM CDT
COVID-19 and Liver Disease: What We’ve Learned So Far
Rita Lepe, MD
10:00 AM – 10:25 AM CDT
Managing Complications of Cirrhosis: Hepatic Encephalopathy and Hepatorenal Syndrome
Steven Flamm, MD
10:25 AM – 10:45 AM CDT
Q&A Panel Discussion
10:45 AM – 11:00 AM CDT
Break
11:00 AM – 11:30 AM CDT
Hepatocellular Cancer: Screening and Treatment Recommendations
Laura Kulik, MD
11:30 AM – 12:00 PM CDT
Biologics and Small Molecule Therapy for IBD: Practical Approaches to Selecting Therapies
Anita Afzali MD, MPH
12:00 PM – 12:20 PM CDT
Q&A / Panel Discussion
12:20 PM - 12:30 PM CDT
Lunch Break
12:30 PM – 1:30 PM CDT
Lunch Product Theater (Non-Accredited)
Rising to the Challenge: Addressing Barriers to HCV Treatment
Parvez Mantry, MD, AGAF
Sponsored by: AbbVie
1:30 PM – 2:30 PM CDT
Parallel Sessions (Select One)
-
Management of GERD and H. Pylori Eradication
-
Case Studies in Inflammatory Bowel Disease (IBD)
-
Detecting and Treating GI and Liver Cancers
-
Diagnosing and Management of Non-alcoholic Fatty Liver Disease (NAFLD) / Non-alcoholic Steatohepatitis (NASH)
2:30 PM – 2:45 PM CDT
Break
2:45 PM – 3:10 PM CDT
Gastroparesis
Lawrence Schiller, MD
3:10 PM – 3:35 PM CDT
Eosinophilic Gastrointestinal Disorders
Stuart Spechler, MD
3:35 PM – 4:00 PM CDT
Latest Advances in Enteroscopy
Daniel Demarco, MD
4:00 PM – 4:25 PM CDT
Diagnosing and Treating IBS-C, OIC, and Chronic Constipation
Lawrence Schiller, MD
4:25 PM – 4:40 PM CDT
Q&A / Panel Discussion
4:40 PM – 4:45 PM CDT
Adjourn
FACULTY
Lawrence Schiller, MD (Course Director)
Program Director, Gastroenterology Fellowship
Baylor University Medical Center
Dallas, Texas
Anita Afzali, MD, MPH, FACG, AGAF
Associate Professor of Medicine
Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease
Medical Director, OSU Inflammatory Bowel Disease Center
Program Director, OSU Advanced Inflammatory Bowel Disease Fellowship
Division of Gastroenterology, Hepatology and Nutrition
The Ohio State University Wexner Medical Center
Columbus, Ohio
Daniel Demarco, MD
Gastroenterology
Baylor Scott & White Research Institute
Dallas, Texas
Steven Flamm, MD
Chief of Hepatology and Liver Transplantation Program
Professor of Medicine and Surgery
Northwestern Feinberg School of Medicine
Chicago, Illinois
Laura Kulik, MD
Professor of Medicine
Transplant Surgery and Interventional Radiology
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Rita Lepe, MD
Director, Hepatology Health Disparities Studies
Assistant Professor of Medicine UT Health San Antonio
Texas Liver Institute
Dallas, Texas
Stuart Spechler, MD
Chief, Division of Gastroenterology
Co-Director, Center for Esophageal Diseases
Baylor University Medical Center at Dallas
Co-Director, Center for Esophageal Research
Baylor Scott & White Research Institute
Dallas, Texas
Mark Sulkowski, MD
Professor of Medicine
Chief, Division of Infectious Diseases
John Hopkins University, Bayview Medical Center
Baltimore, Maryland
VENUE
Westin Dallas Park Central 12720 Merit Drive
Dallas, TX 75251
COVID-19 SAFETY NOTICE
GALA remains diligent in ensuring that the safety and security of our attendees, speakers and staff are top priority while planning the conference. As we move ahead with planning the conference, GALA will continue to place high importance on facilitating measures that will ensure optimal health and sanitary conditions for everyone onsite. COVID-19 state rules and regulations will be strictly followed.
Our onsite safety measures include the following:
-
Social distancing will be strictly followed with a limited number of attendees onsite.
-
Attendees must wear a face covering during the event.
-
Attendees are required to be six feet apart at all times; the conference organizers have arranged seating accordingly to be in compliance with this mandate.
-
Hand sanitizer stations have been placed throughout the meeting space, as well as in the hotel.
-
Signage is being used throughout the meeting space and hotel as a reminder to wear a mask and maintain social distance.
-
Commonly touched surfaces will be cleaned and disinfected by staff as often as possible.
-
Check-in for the event will be socially distanced and managed by the conference organizers for a “touchless” process.
-
Audience questions will be asked through our conference app to eliminate contact through handheld microphones.
-
To ensure the safety of our speakers, in between speaker presentations, there will be a slight delay while the podium, slide advancer, and microphone cover are sanitized.
-
All meals and break items will be served by the hotel staff in accordance with their individual COVID-19 safety procedures and standards.
-
In addition to the safety measures outlined above, please CLICK HERE for a complete list of safety measures that the Westin Dallas Park Central has implemented.